KINIKSA PHARMACEUTICALS INTL

Ticker: KNSA CUSIP: G52694109 Class: Common Stock

Granahan Investment Management, LLC's Holding History (CIK: 0001026710)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 316,213 Value ($000) $13,044 Avg Close $40.11 Range $35.20 - $44.42

Q3 2025

Shares 283,571 Value ($000) $11,011 Avg Close $32.49 Range $26.27 - $39.00

Q2 2025

Shares 310,992 Value ($000) $8,605 Avg Close $25.46 Range $18.25 - $30.69

Q1 2025

Shares 361,894 Value ($000) $8,038 Avg Close $20.58 Range $17.82 - $24.31

Q4 2024

Shares 463,110 Value ($000) $9,160 Avg Close $22.82 Range $19.47 - $28.15

Q3 2024

Shares 507,369 Value ($000) $12,679 Avg Close $24.36 Range $17.38 - $27.92

Q2 2024

Shares 568,735 Value ($000) $10,618 Avg Close $18.73 Range $16.56 - $20.52

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	316,213	$13,044	$40.11	$35.20 - $44.42
Q3 2025	283,571	$11,011	$32.49	$26.27 - $39.00
Q2 2025	310,992	$8,605	$25.46	$18.25 - $30.69
Q1 2025	361,894	$8,038	$20.58	$17.82 - $24.31
Q4 2024	463,110	$9,160	$22.82	$19.47 - $28.15
Q3 2024	507,369	$12,679	$24.36	$17.38 - $27.92
Q2 2024	568,735	$10,618	$18.73	$16.56 - $20.52